DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,115 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $229,000 | -31.4% | 855 | -42.3% | 0.12% | -16.2% |
| Q1 2021 | $334,000 | +1.5% | 1,482 | 0.0% | 0.14% | -8.4% |
| Q4 2020 | $329,000 | -2.4% | 1,482 | -5.4% | 0.16% | -10.4% |
| Q3 2020 | $337,000 | +21.2% | 1,567 | -0.4% | 0.17% | +16.9% |
| Q2 2020 | $278,000 | +19.8% | 1,573 | -6.3% | 0.15% | +0.7% |
| Q1 2020 | $232,000 | -9.0% | 1,679 | +1.0% | 0.15% | +27.8% |
| Q4 2019 | $255,000 | +5.8% | 1,662 | 0.0% | 0.12% | +3.6% |
| Q3 2019 | $241,000 | +0.8% | 1,662 | -0.4% | 0.11% | +0.9% |
| Q2 2019 | $239,000 | -51.3% | 1,669 | -55.2% | 0.11% | -48.1% |
| Q1 2019 | $491,000 | -68.1% | 3,724 | -75.1% | 0.21% | -70.8% |
| Q4 2018 | $1,540,000 | -12.2% | 14,929 | -7.5% | 0.73% | +10.8% |
| Q3 2018 | $1,753,000 | +67.9% | 16,136 | +52.6% | 0.66% | +50.9% |
| Q2 2018 | $1,044,000 | -65.2% | 10,572 | -65.5% | 0.43% | -49.7% |
| Q1 2018 | $3,003,000 | +5.4% | 30,671 | -0.0% | 0.86% | +3.5% |
| Q4 2017 | $2,848,000 | -5.4% | 30,675 | -12.6% | 0.83% | -17.5% |
| Q3 2017 | $3,011,000 | +2.0% | 35,095 | +0.3% | 1.01% | -3.8% |
| Q2 2017 | $2,952,000 | +32.6% | 34,975 | +34.4% | 1.05% | -14.1% |
| Q1 2017 | $2,226,000 | +9.2% | 26,031 | -0.6% | 1.22% | +3.8% |
| Q4 2016 | $2,039,000 | +2.4% | 26,197 | +3.1% | 1.18% | 0.0% |
| Q3 2016 | $1,992,000 | -20.5% | 25,411 | +2.4% | 1.18% | -23.5% |
| Q2 2016 | $2,506,000 | +1.5% | 24,813 | -4.6% | 1.54% | +4.1% |
| Q1 2016 | $2,468,000 | +1.3% | 26,019 | -0.8% | 1.48% | -3.1% |
| Q4 2015 | $2,437,000 | +14.5% | 26,234 | +5.1% | 1.53% | +2.0% |
| Q3 2015 | $2,128,000 | -5.3% | 24,970 | -4.9% | 1.50% | +11.3% |
| Q2 2015 | $2,248,000 | +1.0% | 26,270 | +0.2% | 1.35% | +1.5% |
| Q1 2015 | $2,226,000 | -9.9% | 26,222 | -9.0% | 1.33% | -7.3% |
| Q4 2014 | $2,471,000 | +13.2% | 28,830 | +0.4% | 1.43% | +30.9% |
| Q3 2014 | $2,182,000 | -2.2% | 28,720 | +1.3% | 1.09% | +2.2% |
| Q2 2014 | $2,231,000 | -4.1% | 28,341 | -8.6% | 1.07% | +43.3% |
| Q1 2014 | $2,327,000 | -3.4% | 31,022 | -0.6% | 0.75% | -10.6% |
| Q4 2013 | $2,410,000 | +13.1% | 31,222 | +1.6% | 0.83% | +3.7% |
| Q3 2013 | $2,130,000 | +10.1% | 30,722 | +0.5% | 0.80% | +15.4% |
| Q2 2013 | $1,935,000 | – | 30,572 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |